Benefit of baricitinib for treatment of patients with moderately to severely active SLE is unclear
The work of a clinician-scientist often feels like two steps forward, one step back. Just ask Professor Eric Morand, Head of the School of Clinical Sciences at Monash University.
Feb 27, 2023
0
23